Quantcast
Investor's Business Daily investors.com 09 Nov, 2023 16:30 am

The $2 Billion Bet AstraZeneca Is Making In Weight Loss

The $2 Billion Bet AstraZeneca Is Making In Weight Loss
AZN stock popped Thursday after AstraZeneca said it would spend up to $2.01 billion to license an experimental weight-loss drug from Eccogene.
Read full story at investors.com